Clinical Trial Update: A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating tirzepatide administered at different injection sites across participants with varying body sizes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Individuals

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2023-03-24